Zsolt Megyesfalvi

Neuroendocrine subtypes of small cell lung cancer differ in terms of immune microenvironment and checkpoint molecule distribution

Dávid Dóra, Christopher J. Rivard, Hui Yu et al. · Molecular Oncology · 2020 · 86 citations · Full text

Medicine, Oncology, Pathology +17

Expression patterns and prognostic relevance of subtype‐specific transcription factors in surgically resected small‐cell lung cancer: an international multicenter study

Zsolt Megyesfalvi, Nándor Bárány, András Lantos et al. · The Journal of Pathology · 2022 · 86 citations · Full text

Medicine, Molecular Biology, Oncology +17

Non-small cell lung cancer patients treated with Anti-PD1 immunotherapy show distinct microbial signatures and metabolic pathways according to progression-free survival and PD-L1 status

Dávid Dóra, Balázs Ligeti, Tamás Kovács et al. · OncoImmunology · 2023 · 57 citations · Full text

Life Sciences, Microbiology, Oncology +17

Candida expansion in the gut of lung cancer patients associates with an ecological signature that supports growth under dysbiotic conditions

Bastian Seelbinder, Zoltán Lohinai, Ruben Vazquez-Uribe et al. · Nature Communications · 2023 · 50 citations · Full text

Life Sciences, Biology, Microbiology +17

Dual targeting of BCL-2 and MCL-1 in the presence of BAX breaks venetoclax resistance in human small cell lung cancer

Zsuzsanna Valkó, Zsolt Megyesfalvi, Anna Schwendenwein et al. · British Journal of Cancer · 2023 · 42 citations · Full text

Medicine, Cancer Biology, Oncology +7